| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1059 |
| Trial ID | ChiCTR-ONC-16009567 |
| Disease | Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | HAART |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Anti-CD19 CAR T Cell Immunotherapy for patients with refractory or relapse CD19+ AIDS related lymphoma |
| Year | 2016 |
| Country | China |
| Company sponsor | Shanghai PublicHealth Clinical Center |
| Cohort 1 | |||||||
|
|||||||